- Report
- August 2025
- 384 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 370 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 273 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 395 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 367 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 216 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 550 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 281 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 377 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 377 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 382 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 384 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 468 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 563 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 276 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 204 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 451 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 462 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 369 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 372 Pages
Global
From €5208EUR$5,850USD£4,501GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more